Stock Taper
ASBP
ASPIRE BIOPHARMA HOLDINGS, INC.
NASDAQ
$8.51
▲ UP 3.03% (0.25)

KEY STATISTICS

Market Cap$981.82 K
52w High$23.48
52w Low$0.11
Dividend Yield
Frequency
P/E-0.36
Volume21.47K
Shares Out.115.37K

COMPANY

LEADERSHIP

Kraig T. Higginson
CHIEF EXECUTIVE
Kraig T. Higginson

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 20, 2025
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
2

SPLIT RECORD

DATETYPERATIO
2026-05-11Reverse1:30
2026-01-16Reverse1:40

PRICE

$8.51 ▲ UP 3.03% (+$0.25)
OVERLAYS
$8.00$8.20$8.40$8.609:39 AM10:42 AM11:46 AM12:49 PM1:52 PM2:56 PM3:59 PM8.51

About Aspire Biopharma Holdings, Inc.

https://aspirebiolabs.com ↗

Aspire Biopharma Holdings, Inc., founded in 2021 in Florida, develops innovative sublingual delivery technologies for medications like Instaprin and various other formulations for cardiology, pain, sleep, vitamins, and more.

INDUSTRY

Biotechnology

A PRODUCT ASPIRE BIOPHARMA HOLDINGS, INC. IS KNOWN FOR

BUZZ BOMB™
BUZZ BOMB™

BUZZ BOMB™ is Aspire Biopharma’s flagship sublingual caffeine supplement, quickly absorbed and popular, with 2 million units sold and a new brand identity and e-commerce platform to meet rising demand.

Revenue by Products

IconPRODUCTQ3-2025Q1-2026
Nutraceutical Products$1.94K $28.35K

Revenue by Geography

MapREGIONQ1-2026Q2-2026
UNITED STATES$27.14K $58.03K
International$4.69K
NonUS$729
CANADA$480 $384

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

SECTORS PEERS

PEERPRICE
PALI$1.90COMPARE
ANNA$2.76COMPARE
DARE$2.07COMPARE
BCTX$7.28COMPARE
CRIS$0.85COMPARE
CTXR$0.90COMPARE
PCSA$3.46COMPARE
ADTX$0.84COMPARE